Remote Senior Site Contracts Lead - Pharma & Oncology

Syneos Health, Inc.; Detroit (MI); Remote; USD 80,000 - 140,000; Full time

Benefits offered by this job

Company car or car allowance

Health benefits (medical, dental, and

401k company match

Employee Stock Purchase Plan

Paid time off (PTO) & sick time

Job summary

Syneos Health, Inc. is seeking a Senior Site Contracts Manager (Sponsor Dedicated / Remote – US Based) to develop and negotiate US site budgets and clinical trial agreements for high-impact Pharma & Virus studies.

You will collaborate with internal teams, academic institutions, and stakeholders to drive timely, compliant contracts while minimizing risk and ensuring operational excellence across therapeutic areas, especially oncology.

Qualifications

• 4+ years building budgets and contracts from templates.
• Direct experience negotiating with large academic institutions.
• Ability to juggle priorities, lead projects, and deliver results under tight timelines.
• Strong understanding of clinical study protocols, timelines, and site-related milestones (e.g., SIV).
• Bachelor's degree

Responsibilities

• Develop US site budgets and language for Pharma & Vaccine trials.
• Lead negotiations with academic institutions and stakeholders.
• Draft and finalize CTAs balancing business objectives with protections.
• Escalate budget or language issues and obtain approvals.
• Lead multiple contracting projects across therapeutic areas (oncology preferred).
• Demonstrate proficiency in Excel and CTMS; maintain trackers.

Skills

Budgeting

Contract Negotiation

Project Management

Communication

Clinical Trials

Education

Bachelor's degree

Tools

Excel

CTMS

Job description

Syneos Health, Inc. is seeking a Senior Site Contracts Manager (Sponsor Dedicated / Remote – US Based) to develop and negotiate US site budgets and clinical trial agreements for high-impact Pharma & Virus studies.

You will collaborate with internal teams, academic institutions, and stakeholders to drive timely, compliant contracts while minimizing risk and ensuring operational excellence across therapeutic areas, especially oncology.